GE
Medical/Healthcare
Pharmaceutical
Others
Grifols Egypt for Plasma Derivatives is a partnership between NSPO and Grifols, enhancing Egypt's healthcare system and Grifols' presence in the Middle East and Africa. They aim to achieve self-sufficiency in plasma-derived medicines by setting up 20 donor centers and manufacturing facilities for vital medicines. The project includes testing operations, warehousing, protein purification, and a plasma fractionation plant with an initial capacity of 1 million liters per year, set to double in the future.